In this concise Medical Minute video, become familiar with incretins and review how currently available GLP-1 receptor agonists target multiple pathophysiologic defects in T2D.
Learn about endogenous incretins, their downstream effects, and role in type 2 diabetes.
A brief history of the discovery of incretins and how incretin-based therapies revolutionized modern diabetes care.
In this concise Medical Minute video, review the role of the gut in glucose homeostasis and gain expert insight on how GIP/GLP-1 coagonists may harness multisystemic activity to improve outcomes in persons with T2D.
In this concise Medical Minute video, review the role of the gut in glucose homeostasis and gain expert insight on how GIP/GLP-1 coagonists may harness multisystemic activity to improve outcomes in persons with T2D.
When managing patients with type 2 diabetes, we must understand the complex contribution of obesity and the importance of approaching weight loss for treatment.
In this concise Medical Minute video, gain expert insights on the clinical trial data supporting the use of tirzepatide to improve outcomes in persons with T2D.
Gain expert insights on the clinical trial data supporting the use of tirzepatide to improve outcomes in persons with T2D.
The dual GIP/GLP-1 receptor agonist has demonstrated efficacy in lowering A1C and body weight in the phase III SURPASS trials. Here’s my take on how it may fit into the treatment toolbox for type 2 diabetes.
In this concise Medical Minute video, gain expert insights and guideline-based recommendations for clinical management of persons with T2D and metabolic comorbidities, including cardiovascular disease and obesity.
Gain expert insights on developing individualized treatment for patients with T2D and cardiometabolic comorbidities.
Despite the advent of powerful therapeutics for type 2 diabetes, most patients do not achieve treatment goals. Here’s my take on small practice changes that can improve the care of this chronic, progressive disease.
For further information concerning Lilly grant funding visit www.lillygrantoffice.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.